Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

GlucoTrack, Inc. - Common Stock (NQ:GCTK)

6.080 -0.380 (-5.88%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about GlucoTrack, Inc. - Common Stock

< Previous 1 2 Next >
Glucotrack, Inc. Encourages Shareholders to Vote
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team
Renowned pain management and medical technology leader to accelerate Glucotrack’s strategy for integrated glucose monitoring applications, building on Company’s 2024 expansion into epidural monitoring 
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack, Inc. Reminds Shareholders to Vote
From Glucotrack, Inc.
Via GlobeNewswire
Q3 Virtual Investor Summit: On-Demand Presentations Now Available
Via ACCESS Newswire
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
Via ACCESS Newswire
Glucotrack to Participate in the Q3 Virtual Investor Summit
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
Experienced cardiac electrophysiologist joins Glucotrack’s growing clinical advisory team as the Company advances its long-term CBGM through critical clinical milestones 
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
Company to present endocrinologist perspectives on implantable CBGM technology as it advances toward US pilot study 
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack Announces Repurchase of Series A Warrants
Warrant buyback extinguishes warrant liability accounting and share dilution overhang 
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
Comprehensive analysis confirms safety and strong accuracy of Glucotrack's innovative blood-based continuous glucose monitoring technology, with MARD of 7.7% 
From Glucotrack, Inc.
Via GlobeNewswire
Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management
Via TheNewswire.com
Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
From Glucotrack, Inc.
Via GlobeNewswire
Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives
Via TheNewswire.com
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
Experienced medical device executive with deep expertise in implantable technologies joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology 
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development
Patients get a seat at the table in development of long-term implantable continuous blood glucose monitoring technology 
From Glucotrack, Inc.
Via GlobeNewswire
First-In-Human Study In The Bag, Glucotrack Gears Up For Long-Term Trial Of Potentially Groundbreaking Continuous Blood Glucose Monitor For Diabetes Patients
Via TheNewswire.com
First-In-Human Study In The Bag, Glucotrack Gears Up For Long-Term Trial Of Potentially Groundbreaking Continuous Blood Glucose Monitor For Diabetes Patients
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor
Long-term clinical evaluation represents key advancement following successful first-in-human study 
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes study 
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
Next Generation AI-Driven Analytics to Unlock Key Insights from the Ongoing Continuous Blood Glucose Monitoring Clinical Study Data 
From Glucotrack, Inc.
Via GlobeNewswire
Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care
Via TheNewswire.com
Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes
Safety and performance data from direct blood glucose measurement technology to be featured at international diabetes technology conference 
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology 
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial
By JE Insights, Benzinga 
Via TheNewswire.com
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
The study met its primary endpoint with no procedure or device related serious adverse events reported 
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack Announces Reverse Stock Split
1-for-20 reverse stock split to become effective as of the opening of trading on February 4, 2025 
From Glucotrack, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.